antibiotics

At the cusp of NDA filing for lead antibiotic, AstraZeneca spinout goes private at a fraction of IPO price
Endpoints
Mon, 05/23/22 - 06:45 pm
AstraZeneca
IPOs
Enstasis
antibiotics
Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials
Endpoints
Wed, 05/18/22 - 10:32 am
Locus Biosciences
venture capital
funding
antibiotics
antibacterials
R&D
The antimicrobial pipeline is ‘dry’ and that’s a problem
Pharmaforum
Thu, 05/12/22 - 10:52 am
antibiotics
antibiotic resistance
drug discovery
drug development
New antibiotics still a decade away unless policymakers, investors step up, AMR Action Fund CEO warns
Fierce Biotech
Tue, 04/12/22 - 10:59 am
antibiotics
antibiotic resistance
AMR Action Fund
drug development
Pharma-backed antibiotic fund makes first investments
Pharmaforum
Mon, 04/4/22 - 10:25 am
antibiotics
funding
AMR Action Fund
Venatorx Pharmaceuticals
Adaptive Phage Therapeutics
Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
Endpoints
Wed, 03/30/22 - 10:59 am
Senate
legislation
China
antibiotics
Joe Biden
Venatorx plans new antibiotic filing after phase 3 readout
Pharmaforum
Fri, 03/11/22 - 10:34 am
Venatorx Pharma
antibiotics
clinical trials
antibiotic resistance
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Fierce Biotech
Thu, 03/10/22 - 10:29 am
VenatoRx
antibiotics
clinical trials
FDA
UTIs
Antibiotic resistance startup gets $33M from Boehringer, Novo
Endpoints
Wed, 02/16/22 - 11:02 pm
Centauri Therapeutics
funding
antibiotic resistance
antibiotics
startups
R&D
The pipeline of new antibiotics is drying up. A bill in Congress aims to change that.
BioPharma Dive
Tue, 02/1/22 - 11:36 pm
antibiotics
antibiotic resistance
legislation
drug development
The clock is ticking for Iterum after FDA hands down CRL for Pfizer castoff antibiotic
Endpoints
Mon, 07/26/21 - 10:04 pm
FDA
complete response letter
Iterum
Pfizer
antibiotics
sulopenem
Melinta, bouncing back from bankruptcy, lands FDA approval for speedy skin infection fighter
Fierce Pharma
Mon, 03/15/21 - 11:52 pm
Melinta
antibiotics
FDA
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Stat
Thu, 02/18/21 - 10:45 am
antibiotics
drug development
antibiotic resistance
AMR Action Fund
Henry Skinner
GlaxoSmithKline to shut down antibiotics production, cut 300 jobs in wake of Novartis buyout
Fierce Pharma
Fri, 02/12/21 - 11:09 am
GSK
Novartis
Sandoz
layoffs
antibiotics
drug manufacturing
Novartis' Sandoz doubles down on antibiotics with $500M deal for GSK brands
Fierce Pharma
Thu, 02/11/21 - 10:26 pm
Novartis
Sandoz
generics
antibiotics
Iterum nabs speedy FDA antibiotic review, but follows in the footsteps of bankrupt biotechs
Fierce Biotech
Tue, 01/26/21 - 11:16 am
Iterum
sulopenem
priority review
FDA
UTIs
antibiotics
Wasp toxin inspires new antibiotic that overcomes tough-to-treat sepsis in mice
Fierce Biotech
Mon, 10/12/20 - 08:14 pm
drug development
antibiotics
wasps
sepsis
Bipartisan bill aims to create subscription-style model for bigger antibiotic market
Beckers Hospital Review
Sun, 10/4/20 - 11:04 pm
antibiotics
legislative
subscription model
Novo backs 'breakthrough' antifungal player's $60M round — with a focus on rare mold infections
Endpoints
Wed, 08/12/20 - 10:34 am
drug development
antibiotics
F2G
Novo Nordisk
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections
CP Wire
Mon, 08/3/20 - 10:17 am
Chelation Partners
AMR
ACOA
Canada
antibiotics
antibiotic resistance
patents

Pages